title: Visual, auditory, and somatosensorial evoked potentials in early and late treated adolescents with phenylketonuria.
abstract: Pattern reversal visual, auditory, and somatosensorial evoked potentials were recorded in two groups of phenylketonuric (PKU) adolescents after protracted exposition to high concentrations of phenylalanine following diet discontinuation. The first group consisted of 11 early treated (before age 3 months) PKU patients (ET-PKU); the second group consisted of 11 late detected (after age 8 months), symptomatic, PKU subjects (LT-PKU). Despite the relevant lag between the two groups in mental development and neurological status, no clear-cut difference in evoked potentials could be detected. Only the wave I latency of the brainstem auditory evoked potentials (BAEPs) was significantly shorter in ET- versus LT-PKU children. The P100 latency, I-V interpeak latency (IPL), and I-III IPL seem to discriminate the less severe form of PKU (ET-PKU type 3) from the most severe forms, ET-PKU type 1 plus 2 and LT-PKU. No correlations were found between clinical, biochemical, and neurophysiological parameters. The present data suggest that evoked potentials technique is of limited sensitivity in detecting central nervous system (CNS) alterations in PKU adolescents after diet discontinuation.
authors.affiliation: Istituto di Neuropsichiatria Infantile, Università La Sapienza, Roma, Italy.
authors.forename: V
authors.initials: V
authors.lastname: Leuzzi
authors.forename: F
authors.initials: F
authors.lastname: Cardona
authors.forename: I
authors.initials: I
authors.lastname: Antonozzi
authors.forename: A
authors.initials: A
authors.lastname: Loizzo
mesh_terms: D000293:Adolescent; D000328:Adult; D005069:Evaluation Studies as Topic; D005072:Evoked Potentials, Auditory; D005073:Evoked Potentials, Somatosensory; D005074:Evoked Potentials, Visual; D005260:Female; D006801:Humans; D007361:Intelligence Tests; D008297:Male; D009422:Nervous System Diseases / Q000175:diagnosis* / Q000209:etiology; D010661:Phenylketonurias / Q000150:complications / Q000503:physiopathology* / Q000628:therapy; D012680:Sensitivity and Specificity